ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
22 Sep 2022

Acarix presenterar på Redeye under temat Diagnostik

Den 27 september kl 11.30 kommer Helen Ljungdahl Round, VD på Acarix, att presentera bolagets senaste utveckling inom DiagnostikP...
Continue reading
author-avatar acarix
English, Interim, IR, Listing Regulation, News, Q2, Regulatory, Report
November 18, 2024
25 Aug 2022

Acarix AB (publ) publishes Interim Report, January – June 2022

Significant interest and positive developments in the US marketWe can now conclude that our Go-To-Market strategy in the USA has starte...
Continue reading
author-avatar acarix
Interim, IR, Listing Regulation, News, Q2, Regulatory, Report, Swedish
November 18, 2024
25 Aug 2022

Acarix AB (publ) publicerar delårsrapport, januari – juni 2022

Stort intresse och positiv utveckling på den amerikanska marknadenVi kan nu konstatera att vår Go-To-Market strategi i USA ...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
22 Aug 2022

Invitation to presentation of Acarix´s second quarter report

Acarix will publish its second quarter results on Thursday 25 August 2022 at 08.00 am (CEST). A live webcast will be held at 14.00 (CES...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
22 Aug 2022

Inbjudan till presentation av Acarix delårsrapport för andra kvartalet

Acarix publicerar sin rapport för andra kvartalet torsdagen den 25 augusti 2022 kl 08.00. En direktsänd websändning h&ar...
Continue reading
author-avatar acarix
Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish
November 18, 2024
22 Jun 2022

Acarix tecknar samarbetsavtal med Strategic Health AK för att införa CADScor®System i Alaska

Pressmeddelande Malmö, 22 juni, 2022  Acarix tecknar samarbetsavtal med Strategic Health AK för att inför...
Continue reading
author-avatar acarix
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory
November 18, 2024
22 Jun 2022

Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of Alaska

Press release Malmö, Sweden, June 22, 2022   Acarix partners with Strategic Health AK to roll-out CADScor®Syst...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
10 Jun 2022

Acarix signs additional commercial agreement in US and receives order for CADScor®System in Louisiana.

Press release Malmö, Sweden, June 10, 2022   Acarix signs additional commercial agreement in US and receives order...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
10 Jun 2022

Acarix tecknar ytterligare kommersiellt avtal i USA och erhåller beställning på CADScor®System i Louisiana.

Pressmeddelande Malmö, 10 juni, 2022   Acarix tecknar ytterligare kommersiellt avtal i USA och erhåller bes...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Order, Sales, Swedish
November 18, 2024
03 Jun 2022

Acarix tecknar ytterligare kommersiellt avtal i USA och erhåller snabbt order i både Mississippi och Tennessee

Press release Malmö, 3 Juni, 2022   Acarix tecknar ytterligare kommersiellt avtal i USA och erhåller snabbt...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Order, Sales
November 18, 2024
03 Jun 2022

Acarix signs additional commercial agreement in US and receives rapid orders in both Mississippi and Tennessee

Press release Malmö, Sweden, June 3, 2022   Acarix signs additional commercial agreement in US and receives rapid...
Continue reading
author-avatar acarix
Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish
November 18, 2024
11 May 2022

Kommuniké från årsstämman i Acarix

Pressmeddelande Malmö, 11 maj 2022   Kommuniké från årsstämman i Acarix Årsstä...
Continue reading
  • «
  • ‹
  • 18
  • 19
  • 20
  • 21
  • 22
  • ›
  • »

Acarix AB

Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V6

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.